Canada
· Delayed Price · Currency is CAD UnitedHealth Group Statistics
Total Valuation
UnitedHealth Group has a market cap or net worth of CAD 712.03 billion. The enterprise value is 785.80 billion.
| Market Cap | 712.03B |
| Enterprise Value | 785.80B |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
| Shares Outstanding | n/a |
| Shares Change (YoY) | -1.43% |
| Shares Change (QoQ) | +0.65% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 917.79M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.05 |
| PB Ratio | n/a |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 15.70, with an EV/FCF ratio of 92.51.
| EV / Earnings | 40.71 |
| EV / Sales | 1.47 |
| EV / EBITDA | 15.70 |
| EV / EBIT | 17.75 |
| EV / FCF | 92.51 |
Financial Position
The company has a current ratio of 0.88, with a Debt / Equity ratio of 75.68.
| Current Ratio | 0.88 |
| Quick Ratio | 0.52 |
| Debt / Equity | 75.68 |
| Debt / EBITDA | 2.07 |
| Debt / FCF | 12.10 |
| Interest Coverage | 9.17 |
Financial Efficiency
Return on equity (ROE) is 15.58% and return on invested capital (ROIC) is 12.05%.
| Return on Equity (ROE) | 15.58% |
| Return on Assets (ROA) | 7.07% |
| Return on Capital (ROIC) | 12.05% |
| Revenue Per Employee | 1.20M |
| Profits Per Employee | 43,868 |
| Employee Count | 440,000 |
| Asset Turnover | 1.36 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +8.51% in the last 52 weeks. The beta is 0.60, so UnitedHealth Group's price volatility has been lower than the market average.
| Beta (5Y) | 0.60 |
| 52-Week Price Change | +8.51% |
| 50-Day Moving Average | 24.41 |
| 200-Day Moving Average | 24.67 |
| Relative Strength Index (RSI) | 68.51 |
| Average Volume (20 Days) | 31,384 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 1.74 |
Income Statement
In the last 12 months, UnitedHealth Group had revenue of CAD 527.53 billion and earned 19.30 billion in profits. Earnings per share was 20.72.
| Revenue | 527.53B |
| Gross Profit | 123.80B |
| Operating Income | 43.83B |
| Pretax Income | 27.67B |
| Net Income | 19.30B |
| EBITDA | 47.66B |
| EBIT | 43.83B |
| Earnings Per Share (EPS) | 20.72 |
Balance Sheet
The company has 42.87 billion in cash and 102.78 billion in debt, giving a net cash position of -66.81 billion.
| Cash & Cash Equivalents | 42.87B |
| Total Debt | 102.78B |
| Net Cash | -66.81B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 135.82B |
| Book Value Per Share | 139.63 |
| Working Capital | -17.29B |
Cash Flow
In the last 12 months, operating cash flow was 13.14 billion and capital expenditures -4.64 billion, giving a free cash flow of 8.49 billion.
| Operating Cash Flow | 13.14B |
| Capital Expenditures | -4.64B |
| Free Cash Flow | 8.49B |
| FCF Per Share | n/a |
Margins
Gross margin is 23.47%, with operating and profit margins of 8.31% and 3.66%.
| Gross Margin | 23.47% |
| Operating Margin | 8.31% |
| Pretax Margin | 5.25% |
| Profit Margin | 3.66% |
| EBITDA Margin | 9.03% |
| EBIT Margin | 8.31% |
| FCF Margin | 1.61% |
Dividends & Yields
UnitedHealth Group does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 50.63% |
| Buyback Yield | 1.43% |
| Shareholder Yield | 1.43% |
| Earnings Yield | 77.01% |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |